Annual EBITDA
-$14.97 M
+$3.77 M+20.12%
December 1, 2023
Summary
- As of February 7, 2025, BRTX annual EBITDA is -$14.97 million, with the most recent change of +$3.77 million (+20.12%) on December 1, 2023.
- During the last 3 years, BRTX annual EBITDA has fallen by -$5.46 million (-57.41%).
- BRTX annual EBITDA is now -640.81% below its all-time high of -$2.02 million, reached on December 31, 2010.
Performance
BRTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.24 M
+$182.40 K+7.53%
September 1, 2024
Summary
- As of February 7, 2025, BRTX quarterly EBITDA is -$2.24 million, with the most recent change of +$182.40 thousand (+7.53%) on September 1, 2024.
- Over the past year, BRTX quarterly EBITDA has increased by +$740.30 thousand (+24.85%).
- BRTX quarterly EBITDA is now -176.50% below its all-time high of $2.93 million, reached on June 30, 2020.
Performance
BRTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$11.90 M
+$740.30 K+5.85%
September 1, 2024
Summary
- As of February 7, 2025, BRTX TTM EBITDA is -$11.90 million, with the most recent change of +$740.30 thousand (+5.85%) on September 1, 2024.
- Over the past year, BRTX TTM EBITDA has increased by +$4.45 million (+27.19%).
- BRTX TTM EBITDA is now -3115.64% below its all-time high of -$370.20 thousand, reached on September 30, 2010.
Performance
BRTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BRTX EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +20.1% | +24.9% | +27.2% |
3 y3 years | -57.4% | +43.9% | +54.6% |
5 y5 years | -65.3% | +43.9% | +54.6% |
BRTX EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +42.9% | at high | +61.0% | at high | +54.6% |
5 y | 5-year | -61.1% | +42.9% | -176.5% | +85.1% | -158.0% | +57.1% |
alltime | all time | -640.8% | +42.9% | -176.5% | +85.1% | -3115.6% | +57.1% |
BioRestorative Therapies EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$2.24 M(-7.5%) | -$11.90 M(-5.9%) |
Jun 2024 | - | -$2.42 M(-40.5%) | -$12.64 M(-4.9%) |
Mar 2024 | - | -$4.07 M(+28.0%) | -$13.30 M(-11.2%) |
Dec 2023 | -$14.97 M(-20.1%) | -$3.18 M(+6.7%) | -$14.97 M(-8.4%) |
Sep 2023 | - | -$2.98 M(-3.1%) | -$16.35 M(-8.9%) |
Jun 2023 | - | -$3.08 M(-46.4%) | -$17.95 M(-7.8%) |
Mar 2023 | - | -$5.74 M(+26.0%) | -$19.47 M(+3.9%) |
Dec 2022 | -$18.74 M(-28.5%) | -$4.56 M(-0.5%) | -$18.74 M(+3.1%) |
Sep 2022 | - | -$4.58 M(-0.4%) | -$18.17 M(+5.3%) |
Jun 2022 | - | -$4.60 M(-8.3%) | -$17.26 M(+6.6%) |
Mar 2022 | - | -$5.01 M(+25.7%) | -$16.20 M(-38.2%) |
Dec 2021 | -$26.22 M(+175.7%) | -$3.99 M(+8.7%) | -$26.22 M(-5.5%) |
Sep 2021 | - | -$3.67 M(+3.8%) | -$27.74 M(+11.7%) |
Jun 2021 | - | -$3.53 M(-76.5%) | -$24.84 M(+35.1%) |
Mar 2021 | - | -$15.03 M(+172.9%) | -$18.38 M(+93.4%) |
Dec 2020 | -$9.51 M(+2.4%) | -$5.51 M(+617.0%) | -$9.50 M(+106.0%) |
Sep 2020 | - | -$768.20 K(-126.2%) | -$4.61 M(-33.8%) |
Jun 2020 | - | $2.93 M(-147.5%) | -$6.96 M(-45.1%) |
Mar 2020 | - | -$6.15 M(+897.2%) | -$12.68 M(+36.4%) |
Dec 2019 | -$9.29 M(+2.6%) | -$617.20 K(-80.2%) | -$9.29 M(-19.2%) |
Sep 2019 | - | -$3.12 M(+12.0%) | -$11.50 M(+10.1%) |
Jun 2019 | - | -$2.79 M(+0.5%) | -$10.45 M(+6.6%) |
Mar 2019 | - | -$2.77 M(-1.9%) | -$9.80 M(+8.2%) |
Dec 2018 | -$9.06 M(+11.8%) | -$2.82 M(+36.7%) | -$9.06 M(+18.8%) |
Sep 2018 | - | -$2.07 M(-3.5%) | -$7.62 M(+4.9%) |
Jun 2018 | - | -$2.14 M(+5.8%) | -$7.27 M(-4.7%) |
Mar 2018 | - | -$2.02 M(+45.4%) | -$7.63 M(-5.8%) |
Dec 2017 | -$8.10 M | -$1.39 M(-18.7%) | -$8.10 M(-4.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2017 | - | -$1.71 M(-31.6%) | -$8.52 M(+0.4%) |
Jun 2017 | - | -$2.50 M(+0.5%) | -$8.48 M(+5.2%) |
Mar 2017 | - | -$2.49 M(+37.6%) | -$8.06 M(+5.9%) |
Dec 2016 | -$7.61 M(+7.1%) | -$1.81 M(+8.0%) | -$7.61 M(-10.0%) |
Sep 2016 | - | -$1.68 M(-19.6%) | -$8.46 M(+2.3%) |
Jun 2016 | - | -$2.08 M(+1.9%) | -$8.27 M(+10.3%) |
Mar 2016 | - | -$2.05 M(-23.1%) | -$7.50 M(+5.5%) |
Dec 2015 | -$7.11 M(+36.5%) | -$2.66 M(+79.4%) | -$7.11 M(+21.6%) |
Sep 2015 | - | -$1.48 M(+13.1%) | -$5.84 M(+8.9%) |
Jun 2015 | - | -$1.31 M(-20.9%) | -$5.36 M(+1.4%) |
Mar 2015 | - | -$1.66 M(+18.6%) | -$5.29 M(+1.6%) |
Dec 2014 | -$5.21 M(-1.3%) | -$1.40 M(+39.4%) | -$5.21 M(-2.3%) |
Sep 2014 | - | -$1.00 M(-18.9%) | -$5.33 M(-3.9%) |
Jun 2014 | - | -$1.24 M(-21.3%) | -$5.55 M(+0.8%) |
Mar 2014 | - | -$1.57 M(+3.4%) | -$5.50 M(+4.4%) |
Dec 2013 | -$5.28 M(-9.9%) | -$1.52 M(+24.5%) | -$5.28 M(-9.1%) |
Sep 2013 | - | -$1.22 M(+2.4%) | -$5.80 M(+0.7%) |
Jun 2013 | - | -$1.19 M(-11.1%) | -$5.76 M(-4.6%) |
Mar 2013 | - | -$1.34 M(-34.5%) | -$6.04 M(+0.0%) |
Dec 2012 | -$5.85 M(+57.2%) | -$2.05 M(+73.9%) | -$6.04 M(+30.8%) |
Sep 2012 | - | -$1.18 M(-19.9%) | -$4.62 M(+6.1%) |
Jun 2012 | - | -$1.47 M(+9.7%) | -$4.35 M(+8.8%) |
Mar 2012 | - | -$1.34 M(+113.5%) | -$4.00 M(+7.4%) |
Dec 2011 | -$3.72 M(+84.2%) | -$628.10 K(-31.2%) | -$3.72 M(-12.3%) |
Sep 2011 | - | -$913.10 K(-18.3%) | -$4.25 M(+14.7%) |
Jun 2011 | - | -$1.12 M(+5.1%) | -$3.70 M(+43.3%) |
Mar 2011 | - | -$1.06 M(-7.5%) | -$2.58 M(+70.0%) |
Dec 2010 | -$2.02 M | -$1.15 M(+210.7%) | -$1.52 M(+310.7%) |
Sep 2010 | - | -$370.20 K | -$370.20 K |
FAQ
- What is BioRestorative Therapies annual EBITDA?
- What is the all time high annual EBITDA for BioRestorative Therapies?
- What is BioRestorative Therapies annual EBITDA year-on-year change?
- What is BioRestorative Therapies quarterly EBITDA?
- What is the all time high quarterly EBITDA for BioRestorative Therapies?
- What is BioRestorative Therapies quarterly EBITDA year-on-year change?
- What is BioRestorative Therapies TTM EBITDA?
- What is the all time high TTM EBITDA for BioRestorative Therapies?
- What is BioRestorative Therapies TTM EBITDA year-on-year change?
What is BioRestorative Therapies annual EBITDA?
The current annual EBITDA of BRTX is -$14.97 M
What is the all time high annual EBITDA for BioRestorative Therapies?
BioRestorative Therapies all-time high annual EBITDA is -$2.02 M
What is BioRestorative Therapies annual EBITDA year-on-year change?
Over the past year, BRTX annual EBITDA has changed by +$3.77 M (+20.12%)
What is BioRestorative Therapies quarterly EBITDA?
The current quarterly EBITDA of BRTX is -$2.24 M
What is the all time high quarterly EBITDA for BioRestorative Therapies?
BioRestorative Therapies all-time high quarterly EBITDA is $2.93 M
What is BioRestorative Therapies quarterly EBITDA year-on-year change?
Over the past year, BRTX quarterly EBITDA has changed by +$740.30 K (+24.85%)
What is BioRestorative Therapies TTM EBITDA?
The current TTM EBITDA of BRTX is -$11.90 M
What is the all time high TTM EBITDA for BioRestorative Therapies?
BioRestorative Therapies all-time high TTM EBITDA is -$370.20 K
What is BioRestorative Therapies TTM EBITDA year-on-year change?
Over the past year, BRTX TTM EBITDA has changed by +$4.45 M (+27.19%)